Image_1_Carbapenem-producing Enterobacteriaceae in mothers and newborns in southeast Gabon, 2022.jpeg by Sandra Dos Santos (17929919)

“…Introduction<p>Infections caused by carbapenemase-producing Enterobacteriaceae (CPE) pose a significant threat, leading to severe morbidity and mortality among newborns.…”

Socioeconomic, psychosocial, and family- or society-related factors associated unfavorable treatment outcomes in people with drug-susceptible TB (Gap 4). by Tulip A. Jhaveri (18625800)

“…<p>All studies used multivariable regression and reported adjusted effect estimates [<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref066" target="_blank">66</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref067" target="_blank">67</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref071" target="_blank">71</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref073" target="_blank">73</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref077" target="_blank">77</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref081" target="_blank">81</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref084" target="_blank">84</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref086" target="_blank">86</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref087" target="_blank">87</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref089" target="_blank">89</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref094" target="_blank">94</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref099" target="_blank">99</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref105" target="_blank">105</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref108" target="_blank">108</a>–<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref110" target="_blank">110</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1004409#pmed.1004409.ref123" target="_blank">123</a>]. Estimates greater than 1 represent increased risk of unfavorable outcomes; estimates less than 1 represent decreased risk of unfavorable outcomes. …”

image2_Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomize... by Peng-Le Guo (10432124)

“…The primary endpoint was the proportion of patients with plasma HIV-1 RNA < 50 copies/ml at week 144. Between March 1 and December 31, 2015, a total of 196 patients (from 274 patients screened) were included and randomly assigned to either the DT group (n = 99) or the TT group (n = 97). …”

image1_Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomize... by Peng-Le Guo (10432124)

“…The primary endpoint was the proportion of patients with plasma HIV-1 RNA < 50 copies/ml at week 144. Between March 1 and December 31, 2015, a total of 196 patients (from 274 patients screened) were included and randomly assigned to either the DT group (n = 99) or the TT group (n = 97). …”

image3_Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomize... by Peng-Le Guo (10432124)

“…The primary endpoint was the proportion of patients with plasma HIV-1 RNA < 50 copies/ml at week 144. Between March 1 and December 31, 2015, a total of 196 patients (from 274 patients screened) were included and randomly assigned to either the DT group (n = 99) or the TT group (n = 97). …”

image4_Antiretroviral Long-Term Efficacy and Resistance of Lopinavir/Ritonavir Plus Lamivudine in HIV-1-Infected Treatment-Naïve Patients (ALTERLL): 144-Week Results of a Randomize... by Peng-Le Guo (10432124)

“…The primary endpoint was the proportion of patients with plasma HIV-1 RNA < 50 copies/ml at week 144. Between March 1 and December 31, 2015, a total of 196 patients (from 274 patients screened) were included and randomly assigned to either the DT group (n = 99) or the TT group (n = 97). …”

Table_2_Efficacy of electro-acupuncture in postpartum with diastasis recti abdominis: A randomized controlled clinical trial.xls by Yan Liu (25061)

“…</p>Limitation<p>The frequency intensity of EA parameters was selected between 4 and 6 because of individual tolerance differences.…”

Table_3_Efficacy of electro-acupuncture in postpartum with diastasis recti abdominis: A randomized controlled clinical trial.xls by Yan Liu (25061)

“…</p>Limitation<p>The frequency intensity of EA parameters was selected between 4 and 6 because of individual tolerance differences.…”

Table_1_Efficacy of electro-acupuncture in postpartum with diastasis recti abdominis: A randomized controlled clinical trial.xls by Yan Liu (25061)

“…</p>Limitation<p>The frequency intensity of EA parameters was selected between 4 and 6 because of individual tolerance differences.…”

 Funlocking the Magic of Morocco: Your Ultimate Tour Guide  by Afaq Azeem (16630191)

“…</strong></h3> <p>The question isn't really why go to Morocco, but rather, why not? Nestled between the Mediterranean and the mighty Sahara, Morocco is a tapestry of landscapes. …”

Evaluation of a clinical decision rule to guide antibiotic prescription in children with suspected lower respiratory tract infection in The Netherlands: A stepped-wedge cluster ran... by Josephine S. van de Maat (8384211)

“…We included 999 children (61% male, median age 17 months [IQR 9 to 30]) between 1 January 2016 and 30 September 2018: 597 during the pre-intervention phase and 402 during the intervention phase. …”

A phytotherapeutic approach to hinder the resistance against clindamycin by MRSA: <i>in vitro</i> and <i>in silico</i> studies by Amal Mayyas (20656385)

“…A synergistic test with clindamycin was performed, and molecular docking studies evaluated the interaction between a key compound (<i>trans</i>-cinnamaldehyde) and MRSA protein.…”

Tackling Infections to Benefit Africa (TIBA) – An Inclusive & Equitable Health Research Partnership by Francisca Mutapi (39750)

“…For several decades, children under 5 were excluded from schistosomiasis treatment, creating a significant health inequity. The basis for their exclusion assumed young children did not need treatment and the drug used for treating schistosomiasis would not work effectively in young children. …”

2022-10-21_12-39-13.jpg by Visual Propaganda in Mainland China (12247148)

“…Wind-heat type common cold</p> <p>In the summer, many people like to take cold showers when they are hot and sweaty and sleep and work with the air conditioning on for long periods, resulting in a significant difference between indoor and outdoor temperatures. …”

<b>TaRBench: A Comprehensive Benchmark for Automated Test Case Repair</b> by Ahmadreza Saboor Yaraghi (17389438)

“…However, the maintenance of test cases presents significant challenges, both in terms of complexity and cost. …”

<i>Polygonum cuspidatum</i> inhibits the growth of osteosarcoma cells via impeding Akt/ERK/EGFR signaling pathways by Jun Zhao (59250)

“…</p> <p>CC: Closeness centrality; OS: Osteosarcoma; TCM: Traditional Chinese medicine; NSCLC: Non-small cell lung cancer; DC: Degree centrality; CHM: Chinese herb medicine; BC: Betweenness centrality</p>…”